# SPNS2

## Overview
The SPNS2 gene encodes the SPNS lysolipid transporter 2, a transmembrane protein that is a member of the major facilitator superfamily (MFS). This protein is primarily involved in the transport of sphingosine-1-phosphate (S1P), a critical bioactive lipid that plays a significant role in various physiological processes, including immune system regulation, vascular development, and neural system homeostasis (Spiegel2019New; Duan2023Structural). SPNS2 is characterized by its 12 transmembrane helices, which facilitate its function as a transporter through an alternating-access mechanism typical of MFS proteins (Sauer2023Transport). The protein's ability to export S1P from cells is essential for maintaining the S1P gradient necessary for effective signaling and physiological function, impacting processes such as T cell egress, blood-brain barrier integrity, and cochlear and retinal development (Okuniewska2021SPNS2; Wang2020Mfsd2a). Additionally, SPNS2's involvement in various signaling pathways underscores its clinical significance, particularly in cancer and other diseases (Fang2021Spinster).

## Structure
The SPNS2 protein is a member of the major facilitator superfamily (MFS) and is involved in the transport of sphingosine-1-phosphate (S1P). It consists of 12 transmembrane helices organized into two pseudosymmetrical domains: the N-domain (TM1-6) and the C-domain (TM7-12) (Sauer2023Transport; Duan2023Structural). These domains form a characteristic MFS fold, which is essential for its function as a transporter (Fang2021Spinster).

The SPNS2 structure has been resolved in various conformations, including inward-facing and outward-facing states, which are typical of the alternating-access mechanism used by MFS transporters (Sauer2023Transport; Sharp2024Mechanistic). The protein features a central binding site that is accessible from the cytoplasm in the inward-facing conformation, with the extracellular gate sealed by hydrophobic residues (Sauer2023Transport).

Key residues involved in S1P recognition and transport include R227 and D445, with mutations in these residues significantly affecting transport activity (Duan2023Structural). The structure also includes a hydrophobic pocket formed by residues from TM7, 8, 9, 10, and 12, which is crucial for S1P binding (Duan2023Structural).

## Function
The SPNS2 gene encodes a transporter protein that is crucial for the export of sphingosine-1-phosphate (S1P) from cells. S1P is a bioactive signaling molecule involved in various physiological processes, including immune system regulation, vascular development, and neural system homeostasis (Spiegel2019New; Duan2023Structural). SPNS2 is part of the major facilitator superfamily and specifically belongs to the endosomal spinster subfamily, functioning primarily in the plasma membrane to facilitate S1P's extracellular release (Duan2023Structural).

In the immune system, SPNS2 is essential for generating the S1P gradient between lymph nodes and lymph, which guides T cells out of lymph nodes during an immune response. This function is critical for T cell egress and subsequent immune cell trafficking (Okuniewska2021SPNS2). In the vascular system, SPNS2 contributes to maintaining the blood-brain barrier by ensuring adequate S1P concentrations in brain endothelial cells, which is vital for barrier integrity (Wang2020Mfsd2a).

SPNS2 also plays a role in cochlear and retinal development, bone homeostasis, and lymphocyte trafficking, highlighting its importance in various physiological processes (Spiegel2019New). Its activity is crucial for maintaining the S1P gradient necessary for effective signaling and physiological function.

## Clinical Significance
Mutations and alterations in the expression of the SPNS2 gene have been implicated in several diseases and conditions. In colorectal cancer (CRC), SPNS2 expression is significantly upregulated in colon adenomas and CRC compared to normal tissues, but lower in CRC than in adenomas. Low SPNS2 expression correlates with advanced CRC stages and poor prognosis, suggesting its role as a tumor suppressor. SPNS2 inhibits cell proliferation, migration, epithelial-mesenchymal transition (EMT), invasion, and metastasis in CRC cell lines by upregulating PTEN and inactivating Akt signaling (Lv2021SPNS2).

SPNS2 is also involved in hearing and eye function. Deficiency in SPNS2 leads to early onset progressive hearing loss in mice, with degeneration of the organ of Corti and disorganized cell boundaries. This suggests SPNS2's role in maintaining cochlear homeostasis and sensory hair cell maintenance. SPNS2 deficiency also affects the anterior eye, causing developmental abnormalities and corneal issues, and plays a role in retinal blood vessel formation (Chen2014Spinster).

In cancer, SPNS2 is implicated in cell migration and metastasis. It affects signaling pathways like PI3K/Akt and JAK/STAT3, influencing cancer cell behavior and immune responses (Fang2021Spinster).

## Interactions
SPNS2, a sphingosine-1-phosphate (S1P) transporter, engages in various interactions that are crucial for its function. It is known to interact with sphingosine-1-phosphate receptors (S1PRs), facilitating the transport of S1P to these receptors, which are involved in signaling pathways that influence cell survival and proliferation (Fang2021Spinster). SPNS2 also interacts with sphingosine kinases SPHK1 and SPHK2, which are involved in the generation and signaling of S1P, highlighting its role in the S1P signaling axis (Fang2021Spinster).

The protein's interactions extend to its role in cancer, where it influences pathways such as NF-κB and STAT3, which are critical in the transition from inflammation to cancer (Fang2021Spinster). SPNS2 is also involved in the HGF/c-Met pathway, affecting cancer cell migration through the activation of ERK1/2 and PI3K/AKT pathways (Fang2021Spinster).

Structurally, SPNS2 forms a network of polar interactions that stabilize its conformation, essential for its transport function. These interactions involve specific residues that facilitate the binding and translocation of S1P, as well as the binding of inhibitors that can modulate its activity (Duan2023Structural).


## References


[1. (Duan2023Structural) Yaning Duan, Nancy C. P. Leong, Jing Zhao, Yu Zhang, Dat T. Nguyen, Hoa T. T. Ha, Na Wang, Ruixue Xia, Zhenmei Xu, Zhengxiong Ma, Yu Qian, Han Yin, Xinyan Zhu, Anqi Zhang, Changyou Guo, Yu Xia, Long N. Nguyen, and Yuanzheng He. Structural basis of sphingosine-1-phosphate transport via human spns2. Cell Research, 34(2):177–180, December 2023. URL: http://dx.doi.org/10.1038/s41422-023-00913-0, doi:10.1038/s41422-023-00913-0. This article has 4 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41422-023-00913-0)

[2. (Wang2020Mfsd2a) Zhifu Wang, Yongtao Zheng, Fan Wang, Junjie Zhong, Tong Zhao, Qiang Xie, Tongming Zhu, Fukai Ma, Qisheng Tang, Bin Zhou, and Jianhong Zhu. Mfsd2a and spns2 are essential for sphingosine-1-phosphate transport in the formation and maintenance of the blood-brain barrier. Science Advances, May 2020. URL: http://dx.doi.org/10.1126/sciadv.aay8627, doi:10.1126/sciadv.aay8627. This article has 34 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/sciadv.aay8627)

[3. (Lv2021SPNS2) Lei Lv, Qiyi Yi, Ying Yan, Fengmei Chao, and Ming Li. Spns2 downregulation induces emt and promotes colorectal cancer metastasis via activating akt signaling pathway. Frontiers in Oncology, June 2021. URL: http://dx.doi.org/10.3389/fonc.2021.682773, doi:10.3389/fonc.2021.682773. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2021.682773)

4. (Sauer2023Transport) Transport and inhibition of the sphingosine-1-phosphate exporter SPNS2. This article has 1 citations.

[5. (Okuniewska2021SPNS2) Martyna Okuniewska, Victoria Fang, Audrey Baeyens, Varsha Raghavan, June-Yong Lee, Dan R. Littman, and Susan R. Schwab. Spns2 enables t cell egress from lymph nodes during an immune response. Cell Reports, 36(2):109368, July 2021. URL: http://dx.doi.org/10.1016/j.celrep.2021.109368, doi:10.1016/j.celrep.2021.109368. This article has 12 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.celrep.2021.109368)

6. (Sharp2024Mechanistic) Mechanistic insights into transport models of the sphingolipid transport protein, Spinster homolog 2 (Spns2), using MD simulations. This article has 1 citations.

[7. (Spiegel2019New) Sarah Spiegel, Melissa A. Maczis, Michael Maceyka, and Sheldon Milstien. New insights into functions of the sphingosine-1-phosphate transporter spns2. Journal of Lipid Research, 60(3):484–489, March 2019. URL: http://dx.doi.org/10.1194/jlr.s091959, doi:10.1194/jlr.s091959. This article has 70 citations and is from a peer-reviewed journal.](https://doi.org/10.1194/jlr.s091959)

[8. (Chen2014Spinster) Jing Chen, Neil Ingham, John Kelly, Shalini Jadeja, David Goulding, Johanna Pass, Vinit B. Mahajan, Stephen H. Tsang, Anastasia Nijnik, Ian J. Jackson, Jacqueline K. White, Andrew Forge, Daniel Jagger, and Karen P. Steel. Spinster homolog 2 (spns2) deficiency causes early onset progressive hearing loss. PLoS Genetics, 10(10):e1004688, October 2014. URL: http://dx.doi.org/10.1371/journal.pgen.1004688, doi:10.1371/journal.pgen.1004688. This article has 57 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1004688)

[9. (Fang2021Spinster) Lian Fang, Jiangtao Hou, Yihui Cao, Jia-Jie Shan, and Jie Zhao. Spinster homolog 2 in cancers, its functions and mechanisms. Cellular Signalling, 77:109821, January 2021. URL: http://dx.doi.org/10.1016/j.cellsig.2020.109821, doi:10.1016/j.cellsig.2020.109821. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.cellsig.2020.109821)